Til Stürmer

Dr. Til Stürmer is the Nancy A. Dreyer Distinguished Professor and Chair of the Department of Epidemiology at the UNC Gillings School of Global Public Health. His work focuses on advancing methodologies for nonexperimental treatment comparisons, particularly in pharmacoepidemiology and comparative effectiveness research. He leads one of the world's premier pharmacoepidemiology training programs and has pioneered approaches to address confounding in older adult populations.

• Education: MD (1984, University of Basel), MPH (1993, Harvard University), PhD (2001, University of Heidelberg)
• Leadership: Former ISPE President (2013), FDA Advisory Committee Member, Director of CER at NC TraCS Institute

His research integrates claims data with clinical records to evaluate real-world drug effects, emphasizing older adults often excluded from randomized trials. He has developed propensity score and disease risk score methodologies to mitigate bias in observational studies.

Key contributions include:

• 20-year NIH R01 funding for geriatric pharmacotherapy research
• Over 300 peer-reviewed publications
• Director of UNC's Center for Pharmacoepidemiology

Current roles include editorial positions at American Journal of Epidemiology and Epidemiology.